Brainstorm Cell Therapeutics BCLI

$ 1.24 -1.59%

Quarterly report 2024-Q3
added 11-14-2024

Brainstorm Cell Therapeutics Total Shareholders Equity 2011-2024 | BCLI

Annual Total Shareholders Equity Brainstorm Cell Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-4.86 M	-3.02 M	19.3 M	35.5 M	-12.2 M	5.02 M	5.88 M	9.9 M	14.1 M	6.68 M	2.74 M	3.98 M	1.49 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
35.5 M	-12.2 M	6.5 M

Quarterly Total Shareholders Equity Brainstorm Cell Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-6.06 M	-3.53 M	-5.55 M	-4.86 M	-2.58 M	-3.88 M	-4.84 M	-3.02 M	1.39 M	7.85 M	14.5 M	19.3 M	24.9 M	30.2 M	36.2 M	35.5 M	35.5 M	35.5 M	35.5 M	-12.2 M	-12.2 M	-12.2 M	-12.2 M	5.02 M	5.02 M	5.02 M	5.02 M	5.88 M	5.88 M	5.88 M	5.88 M	9.9 M	9.9 M	9.9 M	9.9 M	14.1 M	14.1 M	14.1 M	14.1 M	6.68 M	6.68 M	6.68 M	6.68 M	2.74 M	2.74 M	2.74 M	2.74 M	3.98 M	3.98 M	3.98 M	3.98 M	1.49 M	1.49 M	1.49 M	1.49 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.2 M	-12.2 M	7.13 M